Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Daiichi Sankyo
Daiichi Sankyo
Children's Hospital Los Angeles
Università Vita-Salute San Raffaele
UNICANCER
Krystal Biotech, Inc.
Arab American University (Palestine)
Shenyang Sunshine Pharmaceutical Co., LTD.
Medicine Invention Design, Inc
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
DEKA Biosciences
Turku University Hospital
RenJi Hospital
Korea University Guro Hospital
BPGbio
Mabwell (Shanghai) Bioscience Co., Ltd.
iTeos Therapeutics
Bnai Zion Medical Center
Persephone Biosciences
Capital Medical University
AbbVie
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of Kentucky
Genelux Corporation
Taichung Tzu Chi Hospital
State Scientific Centre of Coloproctology, Russian Federation
Shanghai Changzheng Hospital
Dana-Farber Cancer Institute
AbbVie
Xi'an Jiaotong University
Charite University, Berlin, Germany
Silenseed Ltd
First Affiliated Hospital of Harbin Medical University
Aduro Biotech, Inc.
Huashan Hospital
Assistance Publique - Hôpitaux de Paris
Oncolytics Biotech
Aduro Biotech, Inc.
GlaxoSmithKline
University of Kentucky
Vanderbilt University Medical Center
National Cancer Center, Korea
University of Utah
Amgen
Shanghai University of Traditional Chinese Medicine
Shenzhen Hornetcorn Bio-technology Company, LTD
New Mexico Cancer Research Alliance
Shenzhen Hornetcorn Bio-technology Company, LTD
University of Utah
ChineseAMS
Shenzhen SiBiono GeneTech Co.,Ltd